Patients News | pharmaphorum

News

Pfizer’s Velsipity heading for NHS use in ulcerative colitis

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use

News

addressing biases in medical device design

Review calls for action on bias with medical devices

Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says a new independent review conducted in the UK.

News

NHS App updates ‘will tap into smart device data’

The UK government plans to link the NHS App to data generated by smart devices, including step counts and heart rate, for example, according to Health Secretary Victoria A

News

UK access disparity resolved as NICE backs RCC therapy

Thousands of UK patients with advanced kidney cancer who have been denied a combination regimen based on Ipsen’s Cabometyx and Bristol-Myers Squibb’s Opdivo will now be ab

News

NICE no follows Scottish aye for rare disease drug Xenpozyme

NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the U

News

FDA clears first OTC glucose biosensor, from Dexcom

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time.

Pfizer’s Velsipity heading for NHS use in ulcerative colitis

Review calls for action on bias with medical devices

NHS App updates ‘will tap into smart device data’

UK access disparity resolved as NICE backs RCC therapy

NICE no follows Scottish aye for rare disease drug Xenpozyme

FDA clears first OTC glucose biosensor, from Dexcom

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks